/ 2 items

#IDYA↓

IDYA/ 10/20/2025 · 8:39 AM

Ideaya Biosciences Stock Jumps on Promising Eye Cancer Treatment Results

Ideaya Biosciences shares rise after reporting breakthrough survival data for rare eye cancer treatment combining darovasertib with Pfizer's Xalkori in clinical trial.

IDYA/ 09/08/2025 · 5:48 AM

IDEAYA's IDE849 Shows Strong Promise for Lung Cancer Patients

IDE849, a new DLL3-targeting drug for SCLC, shows strong efficacy with high response rates (up to 77.1%) and activity in brain metastases. It has a manageable safety profile, offering new hope for patients.